GlassScriptPhysician profile
Chad L Prather
NPI 1710095120
$1,071.45
in general payments reported to CMS, 2019-2025
16 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2021: $60.30 · 2022: $242 · 2023: $155 · 2024: $130 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $481.26 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $107.55 | 2019 | |
| Leo Pharma INC. | $90.57 | 2021-2025 | Anzupgo |
| Allergan, INC. | $69.54 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $53.19 | 2025 | Sotyktu |
| Incyte Corporation | $40.41 | 2022-2024 | Opzelura |
| Organogenesis INC. | $32.10 | 2023 | Puraply |
| Galderma Laboratories, L.P. | $29.49 | 2019-2023 | Epsolay |
| Mimedx Group, INC. | $29.02 | 2024 | |
| Kerecis Limited | $25.34 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Novartis Pharmaceuticals Corporation | $24.49 | 2019 | |
| Medtronic, INC. | $19.08 | 2024 | Venaseal |
| Regeneron Healthcare Solutions, INC. | $18.88 | 2025 | Dupixent |
| Janssen Biotech, INC. | $18.01 | 2022 | |
| Celgene Corporation | $17.76 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $14.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Prather listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.